As GLP-1s become more ubiquitous, leading many to scramble after insurance rejections, both manufacturers are looking to draw in more customers who either prefer to avoid a needle or were unable to swing the out-of-pocket price
Dawood, R., Ismail, B., Alshaikh, A., & Alomar, A
What to do if you're not eligible for the GLP-1 Bridge program Contact the Centers for Medicare & Medicaid Services if you're not sure whether you qualify for the GLP-1 Bridge program
Maternal immune dysregulation and autism-understanding the role of cytokines, chemokines and autoantibodies
The American Diabetes Association Standards of Care emphasizes the importance of monitoring both efficacy and tolerability of GLP-1 therapies, with follow-up frequency individualized based on the specific medication, titration schedule, and patient response